{"id":6109,"date":"2021-12-31T20:03:59","date_gmt":"2022-01-01T01:03:59","guid":{"rendered":"https:\/\/abudinen.com\/blog\/?p=6109"},"modified":"2022-01-07T14:34:41","modified_gmt":"2022-01-07T19:34:41","slug":"tachy","status":"publish","type":"post","link":"https:\/\/abudinen.com\/blog\/2021\/12\/31\/tachy\/","title":{"rendered":"Tachy"},"content":{"rendered":"\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-rumble-com wp-block-embed-rumble-com\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" title=\"The Pfizer Inoculations Do More Harm Than Good\" src=\"https:\/\/rumble.com\/embed\/voaxg5\/?pub=qdzr7#?secret=O25GvqoPGv\" data-secret=\"O25GvqoPGv\" width=\"1920\" height=\"1080\" frameborder=\"0\"><\/iframe>\n<\/div><figcaption>The pfizer inoculation more harm than good<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.canadiancovidcarealliance.org\/media-resources\/the-pfizer-inoculations-for-covid-19-more-harm-than-good-2\/\" rel=\"noopener nofollow\">https:\/\/www.canadiancovidcarealliance.org\/media-resources\/the-pfizer-inoculations-for-covid-19-more-harm-than-good-2\/<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Inventor of mRNA vaccines and RNA as a drug, Bench to Bedside vaccines and biologics consulting. Moderated by @MarioLopezG <a href=\"https:\/\/t.me\/RWMaloneMD\" rel=\"noopener nofollow\">https:\/\/t.me\/RWMaloneMD<\/a> <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Provide absolute risks, not just relative risks. Patients are unduly influenced when risk information is presented using a relative risk approach; this can result in suboptimal decisions. Thus, an absolute risk format should be used. https:\/\/www.fda.gov\/files\/about%20fda\/published\/Communicating-Risk-and-Benefits&#8212;An-Evidence-Based-User%27s-Guide-%28Printer-Friendly%29.pdf <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.fda.gov\/about-fda\/reports\/communicating-risks-and-benefits-evidence-based-users-guide\" rel=\"noopener nofollow\">https:\/\/www.fda.gov\/about-fda\/reports\/communicating-risks-and-benefits-evidence-based-users-guide<\/a> <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">PFIZER\u2019S ORIGINAL TRIAL REPORT<br>DECEMBER 31 2020<br>\u2022 Published in New England Journal of Medicine<br>\u2022 Showed 2 months worth of safety &amp; efficacy data<br>\u2022 Described starting with 43,548 people divided into:<\/p>\n\n\n\n<ol class=\"wp-block-list\"><li>Treatment group (received inoculation)<\/li><li>Control group (received saline)<br>for 2 months to see who developed COVID-19<br>\u2022 The claim was that the inoculations were safe and showed 95% efficacy<br>7 days after the 2nd dose. But that 95% was actually Relative Risk<br>Reduction. Absolute Risk Reduction was only 0.84%.<\/li><\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">The Pfizer 6 month data shows that Pfizer\u2019s COVID-19 inoculations cause more illness than they prevent. Plus, an overview of the Pfizer trial flaws in both design and execution.<a target=\"_blank\" href=\"https:\/\/www.canadiancovidcarealliance.org\/wp-content\/uploads\/2021\/12\/The-COVID-19-Inoculations-More-Harm-Than-Good-REV-Dec-16-2021.pdf\" rel=\"noreferrer noopener nofollow\">Read More<\/a> https:\/\/www.canadiancovidcarealliance.org\/media-resources\/the-pfizer-inoculations-for-covid-19-more-harm-than-good\/<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">READ The Great Tribulation&#8211;Past Or Future?: Two Evangelicals Debate the Question Por Thomas Ice, Kenneth L. Gentry https:\/\/books.google.com.co\/books?id=x02OxlzbNt0C&amp;pg=PA107&amp;lpg=PA107&amp;dq=tachy+revelation+preterism&amp;source=bl&amp;ots=s24PqqsSaI&amp;sig=ACfU3U05tlpWHxRTJnqJLayN2osLXkCGig&amp;hl=es-419&amp;sa=X&amp;ved=2ahUKEwiiyLHigY71AhV9QjABHe1_DpwQ6AF6BAglEAI#v=onepage&amp;q=tachy%20revelation%20preterism&amp;f=false <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Thomas Ice<\/strong>&nbsp;is an American theologian and author of books on biblical prophecy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Education and career<\/strong> Ice received his BA from&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Howard_Payne_University\" rel=\"noopener nofollow\">Howard Payne University<\/a>&nbsp;in 1975, his masters in theology from&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Dallas_Theological_Seminary\" rel=\"noopener nofollow\">Dallas Theological Seminary<\/a>&nbsp;in 1981, and a PhD from&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Tyndale_Theological_Seminary\" rel=\"noopener nofollow\">Tyndale Theological Seminary<\/a>&nbsp;in 1995.<sup><a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Thomas_Ice#cite_note-calvaryprof-1\" rel=\"noopener nofollow\">[1]<\/a><\/sup>&nbsp;He performed post-doctoral studies in church history at the&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/University_of_Wales\" rel=\"noopener nofollow\">University of Wales<\/a>.<sup><a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Thomas_Ice#cite_note-pretribprof-2\" rel=\"noopener nofollow\">[2]<\/a><\/sup><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ice is the executive director of the Pre-Trib Research Center on the campus of&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Liberty_University\" rel=\"noopener nofollow\">Liberty University<\/a>&nbsp;in&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Lynchburg,_Virginia\" rel=\"noopener nofollow\">Lynchburg<\/a>,&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Virginia\" rel=\"noopener nofollow\">Virginia<\/a>.<sup><a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Thomas_Ice#cite_note-pretribprof-2\" rel=\"noopener nofollow\">[2]<\/a>[<em><a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Wikipedia:Accuracy_dispute#Disputed_statement\" rel=\"noopener nofollow\">dubious<\/a>&nbsp;\u2013&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Talk:Thomas_Ice#Dubious\" rel=\"noopener nofollow\">discuss<\/a><\/em>]<\/sup>&nbsp;The research center was founded in 1994 by&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Tim_LaHaye\" rel=\"noopener nofollow\">Tim LaHaye<\/a>&nbsp;and Ice to research, teach, proclaim, and defend&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Rapture\" rel=\"noopener nofollow\">pre-tribulationism<\/a>.<sup><a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Thomas_Ice#cite_note-pretribprof-2\" rel=\"noopener nofollow\">[2]<\/a><\/sup>&nbsp;The center currently sponsors prophecy meetings and conferences and provides speakers for the purpose of discussion and lecture on the topic of pre-tribulationism.<sup>[<em><a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Wikipedia:Citation_needed\" rel=\"noopener nofollow\">citation needed<\/a><\/em>]<\/sup><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ice has taught at Liberty University.<sup>[<em><a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Wikipedia:Manual_of_Style\/Dates_and_numbers#Chronological_items\" rel=\"noopener nofollow\">when?<\/a><\/em>]<\/sup>&nbsp;He moved to&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Calvary_University\" rel=\"noopener nofollow\">Calvary University<\/a>&nbsp;in 2018.<sup><a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Thomas_Ice#cite_note-calvaryprof-1\" rel=\"noopener nofollow\">[1]<\/a><\/sup>&nbsp;He lives in&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Lee%27s_Summit,_Missouri\" rel=\"noopener nofollow\">Lee&#8217;s Summit, Missouri<\/a>, with his wife Janice.<sup><a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Thomas_Ice#cite_note-pretribprof-2\" rel=\"noopener nofollow\">[2]<\/a><\/sup><\/p>\n\n\n\n<ol class=\"wp-block-list\"><li>&nbsp;<a href=\"https:\/\/www.calvary.edu\/dr-tommy-ice\/\" rel=\"noopener nofollow\">&#8220;Dr. Tommy Ice (faculty profile)&#8221;<\/a>. Calvary University. Retrieved&nbsp;February 27,&nbsp;2021.<\/li><li>^&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Thomas_Ice#cite_ref-pretribprof_2-0\" rel=\"noopener nofollow\"><sup><em><strong>a<\/strong><\/em><\/sup><\/a>&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Thomas_Ice#cite_ref-pretribprof_2-1\" rel=\"noopener nofollow\"><sup><em><strong>b<\/strong><\/em><\/sup><\/a>&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Thomas_Ice#cite_ref-pretribprof_2-2\" rel=\"noopener nofollow\"><sup><em><strong>c<\/strong><\/em><\/sup><\/a>&nbsp;<a href=\"https:\/\/en.m.wikipedia.org\/wiki\/Thomas_Ice#cite_ref-pretribprof_2-3\" rel=\"noopener nofollow\"><sup><em><strong>d<\/strong><\/em><\/sup><\/a>&nbsp;<a href=\"https:\/\/www.pre-trib.org\/dr-thomas-ice-about\" rel=\"noopener nofollow\">&#8220;Dr. Thomas Ice (about page)&#8221;<\/a>. Pre-Trib Research Center. Retrieved&nbsp;February 27,&nbsp;2021.<\/li><\/ol>\n\n\n\n<h2 class=\"wp-block-heading\">&#8220;QUICKLY&#8221;: HOW OR WHEN?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">REVIEW http:\/\/www.ldolphin.org\/preterism-ice.html<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We are beginning to see that the current error known as Preterism is based upon the misinterpretations of a few key passages. While Matthew 24:34 and the phrase &#8220;this generation&#8221; is their central passage, their dependence upon the so-called &#8220;time text&#8221; of Revelation becomes important in their attempts to &#8220;preterize&#8221; most of end-time Bible prophecy. Thus, the terms &#8220;quickly&#8221; and &#8220;near&#8221; become the basis for their insistence that the Book of Revelation was fulfilled in the A.D. 70 destruction of Jerusalem. Now I will deal with the term &#8220;quickly.&#8221;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">What Bible verses do Preterists appeal to in an effort to support their understanding of Revelation? &#8220;One of the most helpful interpretive clues in Revelation is . . . the&nbsp;<em>contemporary expectation of the author<\/em>&nbsp;regarding the fulfillment of the prophecies. John clearly expects the&nbsp;<em>soon<\/em>&nbsp;fulfillment of his prophecy,&#8221; says Dr. Ken Gentry. I hope to show that these terms are more properly interpreted as&nbsp;<em>qualitative indicators<\/em>&nbsp;describing how Christ will return. How will He return?; it will be &#8220;quickly&#8221; or &#8220;suddenly.&#8221;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A form of the Greek word for &#8220;quickly&#8221; (<em>t\u00e1chos<\/em>) is used eight times in Revelation (1:1; 2:16; 3:11; 11:14; 22:6; 22:7; 22:12; 22:20).&nbsp;<em>T\u00e1chos&nbsp;<\/em>and its family of related words can be used to mean &#8220;soon&#8221; or &#8220;shortly&#8221; as Preterists believe (relating to time), or it can be used to mean &#8220;quickly&#8221; or &#8220;suddenly&#8221; as many futurists contend (manner in which action occurs). The&nbsp;<em>t\u00e1chos&nbsp;<\/em>family is attested in the Bible as referring to both possibilities. On the one hand, 1 Timothy 3:14 is a timing passage, &#8220;I am writing these things to you, hoping to come to you<strong>&nbsp;<em>before long.<\/em><\/strong>&#8221; On the other hand, Acts 22:18 is descriptive of the manner in which the action takes place, &#8220;and I saw Him saying to me, &#8216;Make haste, and get out of Jerusalem&nbsp;<em>quickly<\/em>, because they will not accept your testimony about Me.'&#8221;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The &#8220;timing interpretation&#8221; of the Preterists teaches that the&nbsp;<em>t\u00e1chos&nbsp;<\/em>word family used in Revelation (1:1; 2:16; 3:11; 11:14; 22:6, 7, 12, 20) means that Christ came in judgment upon Israel through the Roman army in events surrounding the A.D. 70 destruction of Jerusalem. But how would the &#8220;manner interpretation&#8221; of the futurist understand the use of the&nbsp;<em>t\u00e1chos<\/em>&nbsp;family in Revelation? Futurist, John Walvoord explains:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">That which Daniel declared would occur &#8220;in the latter days&#8221; is here described as &#8220;shortly&#8221; (Gr.,&nbsp;<em>en tachei<\/em>), that is, &#8220;quickly or suddenly coming to pass,&#8221; indicating rapidity of execution after the beginning takes place. The idea is not that the event may occur soon, but that when it does, it will be sudden (cf. Luke 18:8; Acts 12:7; 22:18; 25:4; Rom. 16:20). A similar word,&nbsp;<em>tachys<\/em>, is translated &#8220;quickly&#8221; seven times in Revelation (2:5, 16; 3:11; 11:14; 22:7, 12, 20).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Gentry is correct to note universal agreement among lexicons as to the general meaning of the&nbsp;<em>t\u00e1chos&nbsp;<\/em>word family, but these lexicographers generally do not support the preterist interpretation. Dr. Gentry&#8217;s presentation of the lexical evidence is skewed and thus his conclusions are faulty in his effort to support a preterist interpretation of the&nbsp;<em>t\u00e1chos&nbsp;<\/em>word family. We now turn to an examination of how the&nbsp;<em>t\u00e1chos&nbsp;<\/em>word family is used in Revelation.<br><br><strong><em>Support for the Futurist Interpretation<br><br><\/em>1. The lexical use.<\/strong>&nbsp;The leading Greek lexicon in our day is Bauer, Arndt, and Gingrich (BAG), which lists the following definitions for&nbsp;<em>t\u00e1chos<\/em>: &#8220;speed, quickness, swiftness, haste&#8221; (p. 814). The two times that this noun appears in Revelation (1:1; 22:6), it is coupled with the preposition&nbsp;<em>en<\/em>, causing this phrase to function grammatically as an adverb revealing to us the &#8220;sudden&#8221; manner in which these events will take place. They will occur &#8220;swiftly.&#8221; The other word in the&nbsp;<em>t\u00e1chos&nbsp;<\/em>family used in Revelation as an adverb is&nbsp;<em>tach\u00fas<\/em>, which all six times occurs with the verb&nbsp;<em>\u00e9rchomai<\/em>, &#8220;to come&#8221; (2:16; 3:11; 11:14; 22:7, 12, 20). BAG gives as its meaning &#8220;quick, swift, speedy&#8221; (p. 814) and specifically classifies all six uses in Revelation as meaning &#8220;without delay, quickly, at once&#8221; (p. 815). Thus, contrary to the timing assumption of Preterists like Gary DeMar and Ken Gentry, who take every occurrence as a reference to timing, BAG (the other lexicons also agree) recommends a translation&nbsp;<em>descriptive<\/em>&nbsp;of the manner in which things will happen (Rev. 2:16; 3:11; 11:14; 22:7, 12, 20).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A descriptive use of&nbsp;<em>t\u00e1chos<\/em>&nbsp;is also supported by the over 60 times it is cited as the prefix making up a compound word according to the mother of all Greek lexicons, Liddell and Scott (p. 1762). G. H. Lang gives the following example:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><em>tachy<\/em>&nbsp;does not mean&nbsp;<em>soon<\/em>&nbsp;but&nbsp;<em>swiftly<\/em>. It indicates rapidity of action, as is well seen in its accurate use in the medical compound&nbsp;<em>tachycardia<\/em>&nbsp;(<em>tachy&nbsp;<\/em>and&nbsp;<em>kard\u00eda<\/em>=<em>the heart<\/em>), which does not mean that the heart will beat&nbsp;<em>soon<\/em>, but that it is beating&nbsp;<em>rapidly<\/em>. Of course, the swift action may take place at the very same time, as in Mt 28:7-8: &#8220;Go&nbsp;<em>quickly<\/em>&nbsp;and tell His disciples . . . and they departed&nbsp;<em>quickly<\/em>&nbsp;from the tomb&#8221;: but the thought is not that they did not loiter, but that their movement was swift. Thus here also. If the Lord be regarded as speaking in the day when John lived, then He did not mean that He was returning&nbsp;<em>soon<\/em>, but swiftly and suddenly whenever the time should have arrived . . . it is the swiftness of His movement that the word emphasizes.<\/p><\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>2. The grammatical use.<\/strong>&nbsp;Just as BAG is the leading lexicon in our day, the most authoritative Greek grammar is one produced by Blass, Debrunner, and Funk (Blass-Debrunner). Blass-Debrunner, in their section on adverbs, divides them into four categories: 1) adverbs of manner, 2) adverbs of place, 3) adverbs of time, 4) correlative adverbs (pp. 55-57). The&nbsp;<em>t\u00e1chos&nbsp;<\/em>family is used as the major example under the classification of &#8220;adverbs of manner.&#8221; No example from the&nbsp;<em>t\u00e1chos&nbsp;<\/em>family is listed under &#8220;adverbs of time.&#8221; In a related citation, Blass-Debrunner classify&nbsp;<em>en t\u00e1chei<\/em>&nbsp;as an example of &#8220;manner,&#8221; Luke 18:8 (p. 118). Greek scholar Nigel Turner also supports this adverbial sense as meaning &#8220;quickly.&#8221;<br><br>Not only is there a preponderance of lexical support for understanding the&nbsp;<em>t\u00e1chos&nbsp;<\/em>family as including the notion of &#8220;quickly&#8221; or &#8220;suddenly,&#8221; there is the further support that all the occurrences in Revelation are adverbs of manner. These terms are not descriptive of&nbsp;<em>when<\/em>&nbsp;the events will occur and our Lord will come, but rather, descriptive of the&nbsp;<em>manner<\/em>&nbsp;in which they will take place when they occur. These adverbial phrases in Revelation can more accurately be translated &#8220;with swiftness, quickly, all at once, in a rapid pace [when it takes place].&#8221;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>3. The Old Testament (LXX) use.<\/strong>&nbsp;It is significant to note that the Septuagint uses&nbsp;<em>t\u00e1chos&nbsp;<\/em>in passages which even by the most conservative estimations could not have occurred for hundreds, even thousands of years. For example, Isaiah 13:22 says, &#8220;. . . Her (Israel) fateful time also will&nbsp;<em>soon<\/em>&nbsp;come. . .&#8221; This was written around 700 B.C. foretelling the destruction of Babylon which occurred in 539 B.C. Similarly, Isaiah 5:26 speaks of the manner, not the time frame, by which the Assyrian invasion of Israel &#8220;will come with speed&nbsp;<em>swiftly<\/em>.&#8221; Isaiah 51:5 says, &#8220;My righteousness is&nbsp;<em>near<\/em>, My salvation has gone forth, and My arms will judge the peoples; the coastlands will wait for Me, and for My arm they will wait expectantly.&#8221; This passage probably will be fulfilled in the millennium, but no interpreter would place it sooner than Christ&#8217;s first coming, at least 700 years after it was given. Isaiah 58:8 speaks of Israel&#8217;s recovery as &#8220;speedily spring(ing) forth.&#8221; If it is a &#8220;timing passage,&#8221; then the earliest it could have happened is 700 years later, but most likely it has yet to occur. Many other citations in the Septuagint from the&nbsp;<em>t\u00e1chos&nbsp;<\/em>family can be noted in support of the futurist interpretation of the usage in Revelation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>4. The date of Revelation.<\/strong>&nbsp;Dr. Gentry, followed by almost all Preterists have to date the writing of Revelation before the destruction of Jerusalem in A.D. 70. I think this is a very weak view that I will deal with below. [Ireneus]<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>5. A &#8220;timing&#8221; interpretation would require an A.D. 70 fulfillment of the entire book of Revelation.<\/strong>&nbsp;Revelation 22:6, &#8220;And he said to me, &#8216;These words are faithful and true&#8217;; and the Lord, the God of the spirits of the prophets, sent His angel to show to His bond-servants the things which must&nbsp;<em>shortly<\/em>&nbsp;(<em>t\u00e1chos<\/em>) take place.&#8221; This is passage #6 from Gary DeMar&#8217;s list of &#8220;time indicators&#8221; for Revelation as noted above. However, Dr. Gentry cites Revelation 20:7-9 as a reference to the yet future second coming. This creates a contradiction within Gentry&#8217;s brand of Preterism. Since Revelation 22:6 is a statement referring to the whole book of Revelation, it would be impossible to take&nbsp;<em>t\u00e1chos&nbsp;<\/em>as a reference to A.D. 70 (as Dr. Gentry does) and at the same time hold that Revelation 20:7-9 teaches the second coming. Gentry must either adopt a view similar to futurism or shift to the extreme preterist view that understands the entire book of Revelation as past history and thus eliminating any future second coming and resurrection.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">REVIEW Terremoto de San Francisco de 1906<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC297778\/#\" rel=\"noopener nofollow\">Proc Natl Acad Sci U S A.<\/a>&nbsp;1989 Aug; 86(16): 6077\u20136081.doi:&nbsp;<a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1073%2Fpnas.86.16.6077\" rel=\"noreferrer noopener nofollow\">10.1073\/pnas.86.16.6077<\/a>PMCID:&nbsp;PMC297778PMID:&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2762315\" rel=\"noopener nofollow\">2762315<\/a> <strong>Cationic liposome-mediated RNA transfection.<\/strong> <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Malone%20RW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=2762315\" rel=\"noopener nofollow\">R W Malone<\/a>,&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Felgner%20PL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=2762315\" rel=\"noopener nofollow\">P L Felgner<\/a>, and&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Verma%20IM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=2762315\" rel=\"noopener nofollow\">I M Verma<\/a> We have developed an efficient and reproducible method for RNA transfection, using a synthetic cationic lipid, N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA), incorporated into a liposome (lipofectin). Transfection of 10 ng to 5 micrograms of Photinus pyralis luciferase mRNA synthesized in vitro into NIH 3T3 mouse cells yields a linear response of luciferase activity. The procedure can be used to efficiently transfect RNA into human, rat, mouse, Xenopus, and Drosophila cells. Using the RNA\/lipofectin transfection procedure, we have analyzed the role of capping and beta-globin 5&#8242; and 3&#8242; untranslated sequences on the translation efficiency of luciferase RNA synthesized in vitro. Following transfection of NIH 3T3 cells, capped mRNAs with beta-globin untranslated sequences produced at least 1000-fold more luciferase protein than mRNAs lacking these elements. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC297778\/<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Direct Gene Transfer into Mouse Muscle in Vivo<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.1690918#con1\" rel=\"noopener nofollow\">JON A.&nbsp;WOLFF<\/a><a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.1690918#con2\" rel=\"noopener nofollow\">ROBERT W.&nbsp;MALONE<\/a><a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.1690918#con3\" rel=\"noopener nofollow\">PHILLIP&nbsp;WILLIAMS<\/a><a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.1690918#con4\" rel=\"noopener nofollow\">WANG&nbsp;CHONG<\/a><a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.1690918#con5\" rel=\"noopener nofollow\">GYULA&nbsp;ACSADI<\/a><a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.1690918#con6\" rel=\"noopener nofollow\">AGNES&nbsp;JANI<\/a>AND&nbsp;<a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.1690918#con7\" rel=\"noopener nofollow\">PHILIP L.&nbsp;FELGNER<\/a><a href=\"https:\/\/www.science.org\/doi\/10.1126\/science.1690918#tab-contributors\" rel=\"noopener nofollow\">Authors Info &amp; Affiliations<\/a><strong><em>SCIENCE<\/em><\/strong>&nbsp;\u2022&nbsp;23 Mar 1990&nbsp;\u2022&nbsp;Vol&nbsp;247,&nbsp;Issue&nbsp;4949&nbsp;\u2022&nbsp;pp.&nbsp;1465-1468&nbsp;\u2022&nbsp;<a href=\"https:\/\/doi.org\/10.1126\/science.1690918\" rel=\"noopener nofollow\">DOI: 10.1126\/science.1690918<\/a> RNA and DNA expression vectors containing genes for chloramphenicol acetyltransferase, luciferase, and \u03b2-galactosidase were separately injected into mouse skeletal muscle in vivo. Protein expression was readily detected in all cases, and no special delivery system was required for these effects. The extent of expression from both the RNA and DNA constructs was comparable to that obtained from fibroblasts transfected in vitro under optimal conditions. In situ cytochemical staining for \u03b2-galactosidase activity was localized to muscle cells following injection of the \u03b2-galactosidase DNA vector. After injection of the DNA luciferase expression vector, luciferase activity was present in the muscle for at least 2 months. <strong>References<\/strong> ACSADI, G, unpublished data.<a href=\"https:\/\/scholar.google.com\/scholar?q=ACSADI%2C+G%2C+unpublished+data.\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>AUSBEL, F.M.,&nbsp;<em>CURRENT PROTOCOLS MO<\/em>&nbsp;(1989).<a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=CURRENT+PROTOCOLS+MO&amp;publication_year=1989\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>BENVENISTY, N, DIRECT INTRODUCTION OF GENES INTO RATS AND EXPRESSION OF THE GENES,&nbsp;<em>PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA<\/em><strong><em>83<\/em><\/strong>: 9551 (1986).<a href=\"https:\/\/doi.org\/10.1073\/pnas.83.24.9551\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3540943\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=PROCEEDINGS+OF+THE+NATIONAL+ACADEMY+OF+SCIENCES+OF+THE+UNITED+STATES+OF+AMERICA&amp;publication_year=1986&amp;pages=9551&amp;doi=10.1073%2Fpnas.83.24.9551&amp;pmid=3540943\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>DEWET, J.R., FIREFLY LUCIFERASE GENE &#8211; STRUCTURE AND EXPRESSION IN MAMMALIAN-CELLS,&nbsp;<em>MOLECULAR AND CELLULAR BIOLOGY<\/em><strong><em>7<\/em><\/strong>: 725 (1987).<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3821727\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=MOLECULAR+AND+CELLULAR+BIOLOGY&amp;publication_year=1987&amp;pages=725&amp;pmid=3821727\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>DUBENSKY, T.W., DIRECT TRANSFECTION OF VIRAL AND PLASMID DNA INTO THE LIVER OR SPLEEN OF MICE,&nbsp;<em>PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES<\/em><strong><em>81<\/em><\/strong>: 7529 (1984).<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6095303\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=PROCEEDINGS+OF+THE+NATIONAL+ACADEMY+OF+SCIENCES+OF+THE+UNITED+STATES+OF+AMERICA-BIOLOGICAL+SCIENCES&amp;publication_year=1984&amp;pages=7529&amp;pmid=6095303\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>EGLITIS, M.A., RETROVIRAL VECTORS FOR INTRODUCTION OF GENES INTO MAMMALIAN-CELLS,&nbsp;<em>BIOTECHNIQUES<\/em><strong><em>6<\/em><\/strong>: 608 (1988).<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3078718\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=BIOTECHNIQUES&amp;publication_year=1988&amp;pages=608&amp;pmid=3078718\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>FELGNER, P.L.,&nbsp;<em>FOCUS<\/em><strong><em>11<\/em><\/strong>: 21 (1989).<a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=FOCUS&amp;publication_year=1989&amp;pages=21\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>Felgner, P. L.,&nbsp;<em>Nature<\/em><strong><em>337<\/em><\/strong>:387 (1989).<a href=\"https:\/\/doi.org\/10.1038\/337387a0\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2463491\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=Nature&amp;publication_year=1989&amp;pages=387&amp;doi=10.1038%2F337387a0&amp;pmid=2463491\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>FELGNER, P.L., LIPOFECTION &#8211; A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE,&nbsp;<em>PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA<\/em><strong><em>84<\/em><\/strong>: 7413 (1987).<a href=\"https:\/\/doi.org\/10.1073\/pnas.84.21.7413\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2823261\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=PROCEEDINGS+OF+THE+NATIONAL+ACADEMY+OF+SCIENCES+OF+THE+UNITED+STATES+OF+AMERICA&amp;publication_year=1987&amp;pages=7413&amp;doi=10.1073%2Fpnas.84.21.7413&amp;pmid=2823261\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>FINN, G.K., HOMOLOGOUS PLASMID RECOMBINATION IS ELEVATED IN IMMORTALLY TRANSFORMED-CELLS,&nbsp;<em>MOLECULAR AND CELLULAR BIOLOGY<\/em><strong><em>9<\/em><\/strong>: 4009 (1989).<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2550810\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=MOLECULAR+AND+CELLULAR+BIOLOGY&amp;publication_year=1989&amp;pages=4009&amp;pmid=2550810\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>FRANZINIARMSTRO.C,&nbsp;<em>MYOLOGY<\/em>: 125 (1986).<a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=MYOLOGY&amp;publication_year=1986&amp;pages=125\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>FRIEDMANN, T, PROGRESS TOWARD HUMAN-GENE THERAPY,&nbsp;<em>SCIENCE<\/em><strong><em>244<\/em><\/strong>: 1275 (1989).<a href=\"https:\/\/doi.org\/10.1126\/science.2660259\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2660259\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=SCIENCE&amp;publication_year=1989&amp;pages=1275&amp;doi=10.1126%2Fscience.2660259&amp;pmid=2660259\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>GORMAN, C.M., RECOMBINANT GENOMES WHICH EXPRESS CHLORAMPHENICOL ACETYLTRANSFERASE IN MAMMALIAN-CELLS,&nbsp;<em>MOLECULAR AND CELLULAR BIOLOGY<\/em><strong><em>2<\/em><\/strong>: 1044 (1982).<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6960240\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=MOLECULAR+AND+CELLULAR+BIOLOGY&amp;publication_year=1982&amp;pages=1044&amp;pmid=6960240\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>Gorman, C. M.,&nbsp;<em>Proceedings of the National Academy of Sciences of the United States of America<\/em><strong><em>79<\/em><\/strong>: 6777 (1982).<a href=\"https:\/\/doi.org\/10.1073\/pnas.79.22.6777\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6294651\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;publication_year=1982&amp;pages=6777&amp;doi=10.1073%2Fpnas.79.22.6777&amp;pmid=6294651\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>HIRT, B, SELECTIVE EXTRACTION OF POLYOMA DNA FROM INFECTED MOUSE CELL CULTURES,&nbsp;<em>JOURNAL OF MOLECULAR BIOLOGY<\/em><strong><em>26<\/em><\/strong>: 365 (1967).<a href=\"https:\/\/doi.org\/10.1016\/0022-2836(67)90307-5\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4291934\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=JOURNAL+OF+MOLECULAR+BIOLOGY&amp;publication_year=1967&amp;pages=365&amp;doi=10.1016%2F0022-2836%2867%2990307-5&amp;pmid=4291934\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>KANEDA, Y, INCREASED EXPRESSION OF DNA COINTRODUCED WITH NUCLEAR-PROTEIN IN ADULT-RAT LIVER,&nbsp;<em>SCIENCE<\/em><strong><em>243<\/em><\/strong>: 375 (1989).<a href=\"https:\/\/doi.org\/10.1126\/science.2911748\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2911748\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=SCIENCE&amp;publication_year=1989&amp;pages=375&amp;doi=10.1126%2Fscience.2911748&amp;pmid=2911748\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>KRIEG, P.A., FUNCTIONAL MESSENGER-RNAS ARE PRODUCED BY SP6 INVITRO TRANSCRIPTION OF CLONED CDNAS,&nbsp;<em>NUCLEIC ACIDS RESEARCH<\/em><strong><em>12<\/em><\/strong>: 7057 (1984).<a href=\"https:\/\/doi.org\/10.1093\/nar\/12.18.7057\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6207484\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=NUCLEIC+ACIDS+RESEARCH&amp;publication_year=1984&amp;pages=7057&amp;doi=10.1093%2Fnar%2F12.18.7057&amp;pmid=6207484\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>LAVITRANO, M, SPERM CELLS AS VECTORS FOR INTRODUCING FOREIGN DNA INTO EGGS &#8211; GENETIC-TRANSFORMATION OF MICE,&nbsp;<em>CELL<\/em><strong><em>57<\/em><\/strong>: 717 (1989).<a href=\"https:\/\/doi.org\/10.1016\/0092-8674(89)90787-3\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2720785\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=CELL&amp;publication_year=1989&amp;pages=717&amp;doi=10.1016%2F0092-8674%2889%2990787-3&amp;pmid=2720785\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>LEDLEY, F.D., SOMATIC GENE-THERAPY FOR HUMAN-DISEASE &#8211; BACKGROUND AND PROSPECTS .1.,&nbsp;<em>JOURNAL OF PEDIATRICS<\/em><strong><em>110<\/em><\/strong>: 1 (1987).<a href=\"https:\/\/doi.org\/10.1016\/S0022-3476(87)80278-0\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3540245\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=JOURNAL+OF+PEDIATRICS&amp;publication_year=1987&amp;pages=1&amp;doi=10.1016%2FS0022-3476%2887%2980278-0&amp;pmid=3540245\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>MALONE, R.W.,&nbsp;<em>FOCUS<\/em><strong><em>11<\/em><\/strong>: 61 (1989).<a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=FOCUS&amp;publication_year=1989&amp;pages=61\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>MALONE, R.W., CATIONIC LIPOSOME-MEDIATED RNA TRANSFECTION,&nbsp;<em>PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA<\/em><strong><em>86<\/em><\/strong>: 6077 (1989).<a href=\"https:\/\/doi.org\/10.1073\/pnas.86.16.6077\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2762315\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=PROCEEDINGS+OF+THE+NATIONAL+ACADEMY+OF+SCIENCES+OF+THE+UNITED+STATES+OF+AMERICA&amp;publication_year=1989&amp;pages=6077&amp;doi=10.1073%2Fpnas.86.16.6077&amp;pmid=2762315\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>MANNINO, R.J., LIPOSOME MEDIATED GENE-TRANSFER,&nbsp;<em>BIOTECHNIQUES<\/em><strong><em>6<\/em><\/strong>: 682 (1988).<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2856201\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=BIOTECHNIQUES&amp;publication_year=1988&amp;pages=682&amp;pmid=2856201\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>Nicolau, C.,&nbsp;<em>Proceedings of the National Academy of Sciences of the United States of America<\/em><strong><em>80<\/em><\/strong>: 1068 (1983).<a href=\"https:\/\/doi.org\/10.1073\/pnas.80.4.1068\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6341988\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;publication_year=1983&amp;pages=1068&amp;doi=10.1073%2Fpnas.80.4.1068&amp;pmid=6341988\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>NORTON, P.A., BACTERIAL BETA-GALACTOSIDASE AS A MARKER OF ROUS-SARCOMA VIRUS GENE-EXPRESSION AND REPLICATION,&nbsp;<em>MOLECULAR AND CELLULAR BIOLOGY<\/em><strong><em>5<\/em><\/strong>: 281 (1985).<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2983187\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=MOLECULAR+AND+CELLULAR+BIOLOGY&amp;publication_year=1985&amp;pages=281&amp;pmid=2983187\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>PAUZA, C.D., PERSISTENT HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 INFECTION OF MONOBLASTOID CELLS LEADS TO ACCUMULATION OF SELF-INTEGRATED VIRAL-DNA AND TO PRODUCTION OF DEFECTIVE VIRIONS,&nbsp;<em>JOURNAL OF VIROLOGY<\/em><strong><em>63<\/em><\/strong>: 3700 (1989).<a href=\"https:\/\/doi.org\/10.1128\/jvi.63.9.3700-3707.1989\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2760979\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=JOURNAL+OF+VIROLOGY&amp;publication_year=1989&amp;pages=3700&amp;doi=10.1128%2Fjvi.63.9.3700-3707.1989&amp;pmid=2760979\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>PRICE, J, LINEAGE ANALYSIS IN THE VERTEBRATE NERVOUS-SYSTEM BY RETROVIRUS-MEDIATED GENE-TRANSFER,&nbsp;<em>PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA<\/em><strong><em>84<\/em><\/strong>: 156 (1987).<a href=\"https:\/\/doi.org\/10.1073\/pnas.84.1.156\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3099292\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=PROCEEDINGS+OF+THE+NATIONAL+ACADEMY+OF+SCIENCES+OF+THE+UNITED+STATES+OF+AMERICA&amp;publication_year=1987&amp;pages=156&amp;doi=10.1073%2Fpnas.84.1.156&amp;pmid=3099292\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>RALSTON, E, TRANSFER OF A PROTEIN ENCODED BY A SINGLE NUCLEUS TO NEARBY NUCLEI IN MULTINUCLEATED MYOTUBES,&nbsp;<em>SCIENCE<\/em><strong><em>244<\/em><\/strong>: 1066 (1989).<a href=\"https:\/\/doi.org\/10.1126\/science.2543074\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2543074\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=SCIENCE&amp;publication_year=1989&amp;pages=1066&amp;doi=10.1126%2Fscience.2543074&amp;pmid=2543074\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>Reid, T. R.,&nbsp;<em>Journal of Biological Chemistry<\/em><strong><em>264<\/em><\/strong>: 4583 (1989).<a href=\"https:\/\/doi.org\/10.1016\/S0021-9258(18)83783-8\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2925656\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=Journal+of+Biological+Chemistry&amp;publication_year=1989&amp;pages=4583&amp;doi=10.1016%2FS0021-9258%2818%2983783-8&amp;pmid=2925656\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>RUBIO, R, PENETRATION OF HORSERADISH-PEROXIDASE INTO TERMINAL CISTERNAE OF FROG SKELETAL-MUSCLE FIBERS AND BLOCKADE OF CAFFEINE CONTRACTURE BY CA++ DEPLETION,&nbsp;<em>ZEITSCHRIFT FUR ZELLFORSCHUNG UND MIKROSKOPISCHE ANATOMIE<\/em><strong><em>124<\/em><\/strong>: 57 (1972).<a href=\"https:\/\/doi.org\/10.1007\/BF00981941\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4536808\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=ZEITSCHRIFT+FUR+ZELLFORSCHUNG+UND+MIKROSKOPISCHE+ANATOMIE&amp;publication_year=1972&amp;pages=57&amp;doi=10.1007%2FBF00981941&amp;pmid=4536808\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>SEEGER, C, THE CLONED GENOME OF GROUND-SQUIRREL HEPATITIS-VIRUS IS INFECTIOUS IN THE ANIMAL,&nbsp;<em>PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES<\/em><strong><em>81<\/em><\/strong>: 5849 (1984).<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6091114\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=PROCEEDINGS+OF+THE+NATIONAL+ACADEMY+OF+SCIENCES+OF+THE+UNITED+STATES+OF+AMERICA-BIOLOGICAL+SCIENCES&amp;publication_year=1984&amp;pages=5849&amp;pmid=6091114\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>Shimohama, S.,&nbsp;<em>Molecular Brain Research<\/em><strong><em>5<\/em><\/strong>: 271 (1989).<a href=\"https:\/\/doi.org\/10.1016\/0169-328X(89)90061-2\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2501628\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=Molecular+Brain+Research&amp;publication_year=1989&amp;pages=271&amp;doi=10.1016%2F0169-328X%2889%2990061-2&amp;pmid=2501628\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a>WU, G.Y., RECEPTOR-MEDIATED GENE DELIVERY AND EXPRESSION INVIVO,&nbsp;<em>JOURNAL OF BIOLOGICAL CHEMISTRY<\/em><strong><em>263<\/em><\/strong>: 14621 (1988).<a href=\"https:\/\/doi.org\/10.1016\/S0021-9258(18)68081-0\" rel=\"noopener nofollow\">CROSSREF<\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3049582\" rel=\"noopener nofollow\">PUBMED<\/a><a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=JOURNAL+OF+BIOLOGICAL+CHEMISTRY&amp;publication_year=1988&amp;pages=14621&amp;doi=10.1016%2FS0021-9258%2818%2968081-0&amp;pmid=3049582\" rel=\"noopener nofollow\">GOOGLE SCHOLAR<\/a> https:\/\/www.science.org\/doi\/10.1126\/science.1690918<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">REVIEW<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.aimspress.com\/journal\/aimsph\" rel=\"noopener nofollow\">AIMS Public Health<\/a> 2022,&nbsp;<a href=\"https:\/\/www.aimspress.com\/aimsph\/article\/archives\" rel=\"noopener nofollow\">Volume 9<\/a>,&nbsp;<a href=\"https:\/\/www.aimspress.com\/aimsph\/article\/2022\/1\/archive-articles\" rel=\"noopener nofollow\">Issue 1<\/a>:&nbsp;73-93.&nbsp;doi:&nbsp;<a target=\"_blank\" href=\"https:\/\/doi.org\/10.3934\/publichealth.2022007\" rel=\"noreferrer noopener nofollow\">10.3934\/publichealth.2022007<\/a><a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2022006\" rel=\"noopener nofollow\">Previous Article<\/a><a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2022008\" rel=\"noopener nofollow\">Next Article<\/a> Research article <strong>Methodological problems of SARS-CoV-2 rapid point-of-care tests when used in mass testing<\/strong> <a href=\"javascript:void(0);\">Oliver Hirsch<\/a>&nbsp;<sup><a href=\"javascript:void(0);\">1<\/a>&nbsp;,&nbsp;&nbsp;<a href=\"javascript:void(0);\"><\/a>,&nbsp;<a href=\"mailto:oliver.hirsch@fom.de\"><\/a><\/sup>,&nbsp;<a href=\"javascript:void(0);\">Werner Bergholz<\/a>&nbsp;<sup><a href=\"javascript:void(0);\">2<\/a>&nbsp;<\/sup>,&nbsp;<a href=\"javascript:void(0);\">Kai Kisielinski<\/a>&nbsp;<sup><a href=\"javascript:void(0);\">3<\/a>&nbsp;<\/sup>,&nbsp;<a href=\"javascript:void(0);\">Paul Giboni<\/a>&nbsp;<sup><a href=\"javascript:void(0);\">4<\/a>&nbsp;<\/sup>,&nbsp;<a href=\"javascript:void(0);\">Andreas S\u00f6nnichsen<\/a>&nbsp;<sup><a href=\"javascript:void(0);\">5<\/a><\/sup><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>1.Department of Psychology, FOM University of Applied Sciences, Birlenbacher Str. 17, 57078 Siegen, Germany<\/li><li>2.International Standards Consulting GmbH, 30989 Gehrden, Germany<\/li><li>3.Private Practice, 40212 D\u00fcsseldorf, Germany<\/li><li>4.Private Practice, 22763 Hamburg, Germany<\/li><li>5.Department of General Practice and Family Medicine, Center for Public Health, Medical University of Vienna, Wien, Austria<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Received:<\/strong>&nbsp;17 September 2021&nbsp;<strong>Accepted:<\/strong>&nbsp;16 November 2021&nbsp;<strong>Published:<\/strong>&nbsp;23 November 2021 <a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2022007#Abstract\" rel=\"noopener nofollow\">Abstract<\/a> <a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2022007#FullTextWrap\" rel=\"noopener nofollow\">Full Text(HTML)<\/a> <a href=\"javascript:void(0);\">Download PDF<\/a> <a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2022007#Supplements\" rel=\"noopener nofollow\">Supplements<\/a> The aim of the current study is to perform model calculations on the possible use of SARS-CoV-2-rapid point-of-care tests as mass tests, using the quality criteria extracted from evidence-based research as an example for the Federal Republic of Germany. In addition to illustrating the problem of false positive test results, these calculations are used to examine their possible influence on the 7-day incidence. For a substantial period of time, this parameter formed the decisive basis for decisions on measures to protect the population in the wake of the COVID pandemic, which were taken by the government. Primarily, model calculations were performed for a base model of 1,000,000 SARS-CoV-2-rapid point-of-care tests per week using various sensitivities and specificities reported in the literature, followed by sequential testing of the test positives obtained by a SARS-CoV-2 PCR test. Furthermore, a calculation was performed for an actual maximum model based on self-test contingents by the German Federal Ministry of Health. Assuming a number of 1,000,000 tests per week at a prevalence of 0.5%, a high number of false positive test results, a low positive predictive value, a high negative predictive value, and an increase in the 7-day incidence due to the additional antigen rapid tests of approx. 5\/100,000 were obtained. A previous maximum calculation based on contingent numbers for self-tests given by the German Federal Ministry of Health even showed an additional possible influence on the 7-day incidence of 84.6\/100,000. The model calculations refer in each case to representative population samples that would have to be drawn if the successive results were comparable which should be given, as far-reaching actions were based on this parameter. The additionally performed SARS-CoV-2-rapid point-of-care tests increase the 7-day incidence in a clear way depending on the number of tests and clearly show their dependence on the respective number of tests. SARS-CoV-2-rapid point-of-care tests as well as the SARS-CoV-2-PCR test method should both be used exclusively in the presence of corresponding respiratory symptoms and not in symptom-free persons. <a href=\"javascript:void(0);\">SARS-CoV-2<\/a>,&nbsp;<a href=\"javascript:void(0);\">COVID-19<\/a>,&nbsp;<a href=\"javascript:void(0);\">point-of-care diagnostics<\/a>,&nbsp;<a href=\"javascript:void(0);\">rapid testing<\/a>,&nbsp;<a href=\"javascript:void(0);\">methodology<\/a><strong>Citation:<\/strong>&nbsp;Oliver Hirsch, Werner Bergholz, Kai Kisielinski, Paul Giboni, Andreas S\u00f6nnichsen. Methodological problems of SARS-CoV-2 rapid point-of-care tests when used in mass testing[J]. AIMS Public Health, 2022, 9(1): 73-93. doi: 10.3934\/publichealth.2022007<strong>Related Papers:<\/strong>[1]Srikanth Umakanthan, Vijay Kumar Chattu, Anu V Ranade, Debasmita Das, Abhishekh Basavarajegowda, Maryann Bukelo . A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19.&nbsp;AIMS Public Health,&nbsp;2021,&nbsp;8(1): 137-153.&nbsp;<strong>doi:&nbsp;<a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2021011\" rel=\"noopener nofollow\">10.3934\/publichealth.2021011<\/a><\/strong>[2]Mar\u00eda D Figueroa-Pizano, Alma C Campa-Mada, Elizabeth Carvajal-Millan, Karla G Martinez-Robinson, Agustin Rascon Chu . The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review.&nbsp;AIMS Public Health,&nbsp;2021,&nbsp;8(4): 720-742.&nbsp;<strong>doi:&nbsp;<a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2021057\" rel=\"noopener nofollow\">10.3934\/publichealth.2021057<\/a><\/strong>[3]Musyoka Kinyili, Justin B Munyakazi, Abdulaziz YA Mukhtar . Mathematical modeling and impact analysis of the use of COVID Alert SA app.&nbsp;AIMS Public Health,&nbsp;2022,&nbsp;9(1): 106-128.&nbsp;<strong>doi:&nbsp;<a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2022009\" rel=\"noopener nofollow\">10.3934\/publichealth.2022009<\/a><\/strong>[4]Christos Sikaras, Ioannis Ilias, Athanasios Tselebis, Argyro Pachi, Sofia Zyga, Maria Tsironi, Andrea Paola Rojas Gil, Aspasia Panagiotou . Nursing staff fatigue and burnout during the COVID-19 pandemic in Greece.&nbsp;AIMS Public Health,&nbsp;2022,&nbsp;9(1): 94-105.&nbsp;<strong>doi:&nbsp;<a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2022008\" rel=\"noopener nofollow\">10.3934\/publichealth.2022008<\/a><\/strong>[5]Elizabeth Dean, Margot Skinner, Homer Peng-Ming Yu, Alice YM Jones, Rik Gosselink, Anne S\u00f6derlund . Why COVID-19 strengthens the case to scale up assault on non-communicable diseases: role of health professionals including physical therapists in mitigating pandemic waves.&nbsp;AIMS Public Health,&nbsp;2021,&nbsp;8(2): 369-375.&nbsp;<strong>doi:&nbsp;<a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2021028\" rel=\"noopener nofollow\">10.3934\/publichealth.2021028<\/a><\/strong>[6]Yasir Rehman, Nadia Rehman . Association of climatic factors with COVID-19 in Pakistan.&nbsp;AIMS Public Health,&nbsp;2020,&nbsp;7(4): 854-868.&nbsp;<strong>doi:&nbsp;<a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2020066\" rel=\"noopener nofollow\">10.3934\/publichealth.2020066<\/a><\/strong>[7]Aaron C Shang, Kristen E Galow, Gary G Galow . Regional forecasting of COVID-19 caseload by non-parametric regression: a VAR epidemiological model.&nbsp;AIMS Public Health,&nbsp;2021,&nbsp;8(1): 124-136.&nbsp;<strong>doi:&nbsp;<a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2021010\" rel=\"noopener nofollow\">10.3934\/publichealth.2021010<\/a><\/strong>[8]Sadia Minhas, Rabia Mushtaq Chaudhry, Aneequa Sajjad, Iram Manzoor, Atika Masood, Muhammad Kashif . Corona pandemic: awareness of health care providers in Pakistan.&nbsp;AIMS Public Health,&nbsp;2020,&nbsp;7(3): 548-561.&nbsp;<strong>doi:&nbsp;<a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2020044\" rel=\"noopener nofollow\">10.3934\/publichealth.2020044<\/a><\/strong>[9]Athenie Galvez, Jordan Waite, Kyle Jureidini, Kathryn C Nesbit . Integrated care by community health workers in Malawi: Rehabilitation and blood pressure monitoring.&nbsp;AIMS Public Health,&nbsp;2021,&nbsp;8(1): 110-123.&nbsp;<strong>doi:&nbsp;<a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2021009\" rel=\"noopener nofollow\">10.3934\/publichealth.2021009<\/a><\/strong>[10]Yosef Mohamed-Azzam Zakout, Fayez Saud Alreshidi, Ruba Mustafa Elsaid, Hussain Gadelkarim Ahmed . The magnitude of COVID-19 related stress, anxiety and depression associated with intense mass media coverage in Saudi Arabia.&nbsp;AIMS Public Health,&nbsp;2020,&nbsp;7(3): 664-678.&nbsp;<strong>doi:&nbsp;<a href=\"https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2020052\" rel=\"noopener nofollow\">10.3934\/publichealth.2020052<\/a><\/strong> https:\/\/www.aimspress.com\/article\/doi\/10.3934\/publichealth.2022007<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">REVIEW https:\/\/www.isc-team.eu\/werner-bergholz\/<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">PROF. DR. WERNER BERGHOLZ<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>17 years of industrial experience with technical and business responsibilities \u2013 21 years in academia \u2013 23 years in national and international standardization<\/strong><strong>&nbsp;organizations.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">OCCUPATION<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">October 2015 \u2013 today: Partner at ISC International Standards Consulting GmbH &amp; Co. KG, Gehrden, Germany<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">September 2001 \u2013 June 2015 Professor of Electrical Engineering at Jacobs University Bremen, Germany<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><em>Research Topics microelectronic, photovoltaics, quality engineering, standardization<\/em><\/li><li><em>Official retirement 2015<\/em><\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">October 1985 \u2013 August 2001: Siemens Semiconductor Division \/ Infineon Technologies<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><em>Management of a laboratory for crystal defect and contamination analysis for silicon integrated circuit technology de-vice lines \/ Siemens AG, Munich, Germany 1985 \u2013 1990<\/em><\/li><li><em>Head of analysis group of defect and contamination analysis at the 4 Mbit DRAM production plant of Siemens in Regensburg, Germany 1990 \u2013 1994<\/em><\/li><li><em>Worldwide Manager of the Silicon Wafer Supplier Management Group of Siemens, Munich 1995 \u2013 1998<\/em><\/li><li><em>Director of Quality Management and Business Excellence at the Munich Production Plant of the Siemens Semiconductor Group \/ Infineon Technologies 1999 \u2013 2001<\/em><\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Assistant Professor 1978 \u2013 1985 at G\u00f6ttingen University, in this timeframe two research visits at Arhus University, DK (April to October 1979) and Oxford University, UK (mid 1983 \u2013 mid 1985).<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><em>Research topics metal contamination and intrinsic gettering \/ oxygen in silicon<\/em><\/li><\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">EDUCATION<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">April 1975: Diploma from G\u00f6ttingen University Germany in Semiconductor Physics<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">July 1978: Dr. rer. nat. from G\u00f6ttingen University Germany in Semiconductor Physics<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">TRACK RECORD IN STANDARDIZATION<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">20 years in international standardization in IEC &amp; SEMI.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">16 years as the vice chairman of the German mirror committee to IEC\/TC 113 \u201cNanoelectronics\u201c.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">8 years as convenor of WG 3 of IEC\/TC 113.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">8 years as assistant secretary of IEC\/TC 113.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">17 years SEMI European Regional Technical Committee Co-Chair and Co-Chair of the TC silicon wafers and member of the SEMI Audit and Review Committee.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">AWARDS<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">2012: IEC 1906 Award for his contribution to the nanotechnology standardization activities within the IEC.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">2009: Award for contribution to the German Quality Award (Ludwig Erhard Preis) as an Assessor according to the EFQM Model for excellence.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">2005: Karl Urbanek Award for his contributions to the SEMI International Standards program.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.dsalud.com\/reportaje\/afirman-que-tanto-los-test-de-antigenos-como-la-pcr-son-toxicos\/\" rel=\"noopener nofollow\">https:\/\/www.dsalud.com\/reportaje\/afirman-que-tanto-los-test-de-antigenos-como-la-pcr-son-toxicos\/<\/a> Werner Begholz, f\u00edsico alem\u00e1n experto en Microelectr\u00f3nica y Nanoelectr\u00f3nica, ha presentado en el \u00faltimo a\u00f1o y medio varios informes ante el&nbsp;<em>Comit\u00e9 de Salud&nbsp;<\/em>del Bundestag (el parlamento alem\u00e1n) en los que afirma que tanto los hisopos como los reactivos que se utilizan en los test de ant\u00edgenos y en la PCR hay sustancias t\u00f3xicas para la salud y el medio ambiente.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.dsalud.com\/reportaje\/existen-componentes-toxicos-no-declarados-en-las-vacunas-covid\/\" rel=\"noopener nofollow\">https:\/\/www.dsalud.com\/reportaje\/existen-componentes-toxicos-no-declarados-en-las-vacunas-covid\/<\/a> \u00bfExisten componentes t\u00f3xicos no declarados en las \u201cvacunas Covid\u201d? N\u00famero 255 &#8211; Enero 2022 <strong>En las propias fichas t\u00e9cnicas de las \u00abvacunas Covid\u00bb se reconoce que pueden provocar trastornos del sistema inmune, trastornos de la sangre y del sistema linf\u00e1tico, trastornos vasculares, trastornos del sistema respiratorio, tor\u00e1cico y median\u00edstico, trastornos psiqui\u00e1tricos, trastornos del sistema nervioso, trastornos gastrointestinales y trastornos musculoesquel\u00e9ticos y del tejido conjuntivo. Las dolencias concretas -numerosas- dependen de cada vacuna y ya las dimos a conocer pero las resumimos de nuevo en un recuadro al final de este art\u00edculo. Asimismo se conocen los componentes declarados que llevan pero \u00bfaparecen todos? Porque hay quienes afirman que existen otros dif\u00edciles de detectar, especialmente si se trata de nanopart\u00edculas o fragmentos de ADN o ARN. Es el caso de los componentes de grafeno que el doctor Pablo Campra Madrid afirm\u00f3 este verano haber detectado en un vial y ha vuelto a encontrar en siete m\u00e1s tras hacer nuevos an\u00e1lisis cuyos resultados ha publicado en un segundo informe. Es m\u00e1s, hay quienes sugieren que se est\u00e1n introduciendo en los humanos a trav\u00e9s de las vacunas micropart\u00edculas de grafeno u otros nanomateriales que tras interactuar con el ADN permiten emitir y recibir se\u00f1ales que pueden captarse a trav\u00e9s del bluetooth de un m\u00f3vil. Hemos analizado qu\u00e9 hay de cierto en todo ello.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acusan a Bill Gates de querer controlar el mercado mundial de semillas y la biodiversidad N\u00famero 243 &#8211; Diciembre 2020 <strong>El movimiento creado para proteger la biodiversidad de la Tierra y los derechos de los agricultores a guardar, intercambiar y desarrollar semillas&nbsp;<em>Navdanya International<\/em>&nbsp;afirma que tras la iniciativa&nbsp;<em>Gates AgOne<\/em>&nbsp;se esconde \u00ab<em>la intenci\u00f3n de crear un imperio sobre la vida y la biodiversidad, sobre la alimentaci\u00f3n y la agricultura y sobre nuestro pan de cada d\u00eda<\/em>\u00ab. Asevera que Bill Gates quiere tener el control absoluto de las semillas de todo el planeta. La fundadora del movimiento, Vandana Shiva, agrega que el filantrocapitalismo que personifica la<em>&nbsp;Fundaci\u00f3n Bill y Melinda Gates<\/em>&nbsp;va a llevarnos al colapso ecol\u00f3gico.<\/strong> https:\/\/www.dsalud.com\/reportaje\/acusan-a-bill-gates-de-querer-controlar-el-mercado-mundial-de-semillas-y-la-biodiversidad\/<\/p>\n","protected":false},"excerpt":{"rendered":"<p>https:\/\/www.canadiancovidcarealliance.org\/media-resources\/the-pfizer-inoculations-for-covid-19-more-harm-than-good-2\/ Inventor of mRNA vaccines and RNA as a drug, Bench to Bedside vaccines and biologics consulting. Moderated by @MarioLopezG https:\/\/t.me\/RWMaloneMD Provide absolute risks, not just relative risks. Patients are unduly influenced &#8230; <a title=\"Tachy\" class=\"read-more\" href=\"https:\/\/abudinen.com\/blog\/2021\/12\/31\/tachy\/\" aria-label=\"Read more about Tachy\">Leer m\u00e1s<\/a><\/p>\n<p class=\"social-share asbm-share-block\"><strong class=\"asbm-share-title\">Sharing is caring<\/strong><a href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fabudinen.com%2Fblog%2F2021%2F12%2F31%2Ftachy%2F\" target=\"_blank\" rel=\"noopener\" class=\"asbm-share asbm-share--facebook\" aria-label=\"Compartir en Facebook\"><svg viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"currentColor\" aria-hidden=\"true\"><path d=\"M9.101 23.691v-7.98H6.627v-3.667h2.474v-1.58c0-4.085 1.848-5.978 5.858-5.978.401 0 .955.042 1.468.103a8.68 8.68 0 0 1 1.141.195v3.325a8.623 8.623 0 0 0-.653-.036 26.805 26.805 0 0 0-.733-.009c-.707 0-1.259.096-1.675.309a1.686 1.686 0 0 0-.679.622c-.258.42-.374.995-.374 1.752v1.297h3.919l-.386 2.103-.287 1.564h-3.246v8.245C19.396 23.238 24 18.179 24 12.044c0-6.627-5.373-12-12-12s-12 5.373-12 12c0 5.628 3.874 10.35 9.101 11.647z\"\/><\/svg><span class=\"asbm-share__label\">Facebook<\/span><\/a><a href=\"https:\/\/twitter.com\/intent\/tweet?text=Tachy&#038;url=https%3A%2F%2Fabudinen.com%2Fblog%2F2021%2F12%2F31%2Ftachy%2F\" target=\"_blank\" rel=\"noopener\" class=\"asbm-share asbm-share--twitter\" aria-label=\"Compartir en X \/ Twitter\"><svg viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"currentColor\" aria-hidden=\"true\"><path d=\"M18.244 2.25h3.308l-7.227 8.26 8.502 11.24H16.17l-5.214-6.817L4.99 21.75H1.68l7.73-8.835L1.254 2.25H8.08l4.713 6.231zm-1.161 17.52h1.833L7.084 4.126H5.117z\"\/><\/svg><span class=\"asbm-share__label\">X \/ Twitter<\/span><\/a><a href=\"https:\/\/www.linkedin.com\/shareArticle?mini=true&#038;url=https%3A%2F%2Fabudinen.com%2Fblog%2F2021%2F12%2F31%2Ftachy%2F\" target=\"_blank\" rel=\"noopener\" class=\"asbm-share asbm-share--linkedin\" aria-label=\"Compartir en LinkedIn\"><svg viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"currentColor\" aria-hidden=\"true\"><path d=\"M20.447 20.452h-3.554v-5.569c0-1.328-.027-3.037-1.852-3.037-1.853 0-2.136 1.445-2.136 2.939v5.667H9.351V9h3.414v1.561h.046c.477-.9 1.637-1.85 3.37-1.85 3.601 0 4.267 2.37 4.267 5.455v6.286zM5.337 7.433a2.062 2.062 0 01-2.063-2.065 2.063 2.063 0 112.063 2.065zm1.782 13.019H3.555V9h3.564v11.452zM22.225 0H1.771C.792 0 0 .774 0 1.729v20.542C0 23.227.792 24 1.771 24h20.451C23.2 24 24 23.227 24 22.271V1.729C24 .774 23.2 0 22.222 0h.003z\"\/><\/svg><span class=\"asbm-share__label\">LinkedIn<\/span><\/a><a href=\"https:\/\/wa.me\/?text=Tachy%20https%3A%2F%2Fabudinen.com%2Fblog%2F2021%2F12%2F31%2Ftachy%2F\" target=\"_blank\" rel=\"noopener\" class=\"asbm-share asbm-share--whatsapp\" aria-label=\"Compartir en WhatsApp\"><svg viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"currentColor\" aria-hidden=\"true\"><path d=\"M17.472 14.382c-.297-.149-1.758-.867-2.03-.967-.273-.099-.471-.148-.67.15-.197.297-.767.966-.94 1.164-.173.199-.347.223-.644.075-.297-.15-1.255-.463-2.39-1.475-.883-.788-1.48-1.761-1.653-2.059-.173-.297-.018-.458.13-.606.134-.133.298-.347.446-.52.149-.174.198-.298.298-.497.099-.198.05-.371-.025-.52-.075-.149-.669-1.612-.916-2.207-.242-.579-.487-.5-.669-.51-.173-.008-.371-.01-.57-.01-.198 0-.52.074-.792.372-.272.297-1.04 1.016-1.04 2.479 0 1.462 1.065 2.875 1.213 3.074.149.198 2.096 3.2 5.077 4.487.709.306 1.262.489 1.694.625.712.227 1.36.195 1.871.118.571-.085 1.758-.719 2.006-1.413.248-.694.248-1.289.173-1.413-.074-.124-.272-.198-.57-.347M12.05 21.785h-.004a9.87 9.87 0 01-5.031-1.378l-.361-.214-3.741.982.998-3.648-.235-.374a9.86 9.86 0 01-1.51-5.26c.001-5.45 4.436-9.884 9.888-9.884 2.64 0 5.122 1.03 6.988 2.898a9.825 9.825 0 012.893 6.994c-.003 5.45-4.437 9.884-9.885 9.884m8.413-18.297A11.815 11.815 0 0012.05 0C5.495 0 .16 5.335.157 11.892c0 2.096.547 4.142 1.588 5.945L.057 24l6.305-1.654a11.882 11.882 0 005.683 1.448h.005c6.554 0 11.89-5.335 11.893-11.893a11.821 11.821 0 00-3.48-8.413z\"\/><\/svg><span class=\"asbm-share__label\">WhatsApp<\/span><\/a><a href=\"https:\/\/t.me\/share\/url?url=https%3A%2F%2Fabudinen.com%2Fblog%2F2021%2F12%2F31%2Ftachy%2F&#038;text=Tachy\" target=\"_blank\" rel=\"noopener\" class=\"asbm-share asbm-share--telegram\" aria-label=\"Compartir en Telegram\"><svg viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"currentColor\" aria-hidden=\"true\"><path d=\"M11.944 0A12 12 0 0 0 0 12a12 12 0 0 0 12 12 12 12 0 0 0 12-12A12 12 0 0 0 12 0a12 12 0 0 0-.056 0zm4.962 7.224c.1-.002.321.023.465.14a.506.506 0 0 1 .171.325c.016.093.036.306.02.472-.18 1.898-.962 6.502-1.36 8.627-.168.9-.499 1.201-.82 1.23-.696.065-1.225-.46-1.9-.902-1.056-.693-1.653-1.124-2.678-1.8-1.185-.78-.417-1.21.258-1.91.177-.184 3.247-2.977 3.307-3.23.007-.032.014-.15-.056-.212s-.174-.041-.249-.024c-.106.024-1.793 1.14-5.061 3.345-.48.33-.913.49-1.302.48-.428-.008-1.252-.241-1.865-.44-.752-.245-1.349-.374-1.297-.789.027-.216.325-.437.893-.663 3.498-1.524 5.83-2.529 6.998-3.014 3.332-1.386 4.025-1.627 4.476-1.635z\"\/><\/svg><span class=\"asbm-share__label\">Telegram<\/span><\/a><a href=\"https:\/\/reddit.com\/submit?url=https%3A%2F%2Fabudinen.com%2Fblog%2F2021%2F12%2F31%2Ftachy%2F&#038;title=Tachy\" target=\"_blank\" rel=\"noopener\" class=\"asbm-share asbm-share--reddit\" aria-label=\"Compartir en Reddit\"><svg viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"currentColor\" aria-hidden=\"true\"><path d=\"M12 0A12 12 0 0 0 0 12a12 12 0 0 0 12 12 12 12 0 0 0 12-12A12 12 0 0 0 12 0zm5.01 4.744c.688 0 1.25.561 1.25 1.249a1.25 1.25 0 0 1-2.498.056l-2.597-.547-.8 3.747c1.824.07 3.48.632 4.674 1.488.308-.309.73-.491 1.207-.491.968 0 1.754.786 1.754 1.754 0 .716-.435 1.333-1.01 1.614a3.111 3.111 0 0 1 .042.52c0 2.694-3.13 4.87-7.004 4.87-3.874 0-7.004-2.176-7.004-4.87 0-.183.015-.366.043-.534A1.748 1.748 0 0 1 4.028 12c0-.968.786-1.754 1.754-1.754.463 0 .898.196 1.207.49 1.207-.883 2.878-1.43 4.744-1.487l.885-4.182a.342.342 0 0 1 .14-.197.35.35 0 0 1 .238-.042l2.906.617a1.214 1.214 0 0 1 1.108-.701zM9.25 12C8.561 12 8 12.562 8 13.25c0 .687.561 1.248 1.25 1.248.687 0 1.248-.561 1.248-1.249 0-.688-.561-1.249-1.249-1.249zm5.5 0c-.687 0-1.248.561-1.248 1.25 0 .687.561 1.248 1.249 1.248.688 0 1.249-.561 1.249-1.249 0-.687-.562-1.249-1.25-1.249zm-5.466 3.99a.327.327 0 0 0-.231.094.33.33 0 0 0 0 .463c.842.842 2.484.913 2.961.913.477 0 2.105-.056 2.961-.913a.361.361 0 0 0 .029-.463.33.33 0 0 0-.464 0c-.547.533-1.684.73-2.512.73-.828 0-1.979-.196-2.512-.73a.326.326 0 0 0-.232-.095z\"\/><\/svg><span class=\"asbm-share__label\">Reddit<\/span><\/a><a href=\"mailto:?subject=Tachy&#038;body=https%3A%2F%2Fabudinen.com%2Fblog%2F2021%2F12%2F31%2Ftachy%2F\" class=\"asbm-share asbm-share--email\" aria-label=\"Compartir en Email\"><svg viewBox=\"0 0 24 24\" width=\"18\" height=\"18\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" aria-hidden=\"true\"><rect x=\"2\" y=\"4\" width=\"20\" height=\"16\" rx=\"2\"\/><path d=\"m22 7-8.97 5.7a1.94 1.94 0 0 1-2.06 0L2 7\"\/><\/svg><span class=\"asbm-share__label\">Email<\/span><\/a><span class=\"asbm-share-meta\">4546 words \u00b7 167 views<\/span><\/p>","protected":false},"author":1,"featured_media":6293,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6109","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categoria"],"_links":{"self":[{"href":"https:\/\/abudinen.com\/blog\/wp-json\/wp\/v2\/posts\/6109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/abudinen.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/abudinen.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/abudinen.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/abudinen.com\/blog\/wp-json\/wp\/v2\/comments?post=6109"}],"version-history":[{"count":35,"href":"https:\/\/abudinen.com\/blog\/wp-json\/wp\/v2\/posts\/6109\/revisions"}],"predecessor-version":[{"id":6270,"href":"https:\/\/abudinen.com\/blog\/wp-json\/wp\/v2\/posts\/6109\/revisions\/6270"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/abudinen.com\/blog\/wp-json\/wp\/v2\/media\/6293"}],"wp:attachment":[{"href":"https:\/\/abudinen.com\/blog\/wp-json\/wp\/v2\/media?parent=6109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/abudinen.com\/blog\/wp-json\/wp\/v2\/categories?post=6109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/abudinen.com\/blog\/wp-json\/wp\/v2\/tags?post=6109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}